Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
25.9M
-
Shares change
-
+4.98M
-
Total reported value, excl. options
-
$425M
-
Value change
-
+$86.2M
-
Number of buys
-
39
-
Number of sells
-
-30
-
Price
-
$16.39
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2015
88 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q4 2015.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.9M shares
of 49.8M outstanding shares and own 52.07% of the company stock.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (6.42M shares), Woodford Investment Management Ltd (5.06M shares), VANGUARD GROUP INC (1.8M shares), FMR LLC (1.8M shares), BlackRock Fund Advisors (1.58M shares), OppenheimerFunds, Inc. (1.1M shares), FIRST MANHATTAN CO (1.06M shares), BlackRock Institutional Trust Company, N.A. (684K shares), Rock Springs Capital Management LP (645K shares), and STATE STREET CORP (529K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.